Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-055179
Filing Date
2018-10-16
Accepted
2018-10-16 18:03:25
Documents
2
Period of Report
2018-10-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2178
2 POA DOCUMENT poa.txt EX-24.3_813721 3450
  Complete submission text file 0001209191-18-055179.txt   7098
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Issuer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERSARTIS, INC. 1020 MARSH ROAD MENLO PARK CA 94025
Business Address
Shah Vinay (Reporting) CIK: 0001753078 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36361 | Film No.: 181125140